Treatments After Progression on First-Line FOLFOXIRI and Bevacizumab in Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Treatments After Progression to First-Line FOLFOXIRI and Bevacizumab in Metastatic Colorectal Cancer: A Pooled Analysis of TRIBE and TRIBE2 Studies by GONO
Br. J. Cancer 2020 Oct 07;[EPub Ahead of Print], D Rossini, S Lonardi, C Antoniotti, D Santini, G Tomasello, P Ermacora, MM Germani, F Bergamo, V Ricci, S Caponnetto, R Moretto, A Zaniboni, F Pietrantonio, A Buonadonna, G Ritorto, G Masi, TP Latiano, S Rapisardi, A Falcone, C CremoliniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.